stockrow
Friday 6 November 2026
Export STAA’s income statement to Excel — free account
STAAR Surgical Company
STAA Healthcare Medical Instruments & Supplies
STAAR Surgical Company’s revenue for fiscal 2025 (year ended December 2025) was $239.4 million, down 23.7% from fiscal 2024.
- Revenue
- −12.0%
- EPS
- −38.9%
- Free cash flow
- +1,378.7%
Quarter to September 2026, against a year earlier
25.68
1.04
−3.89%
Follow STAA
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 0.15% | 1.09% | (5.99%) | (21.70%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 5 | 4 | 1 | |
| 0.11% | 0.84% | (4.63%) | (16.74%) | ||
ROIC |
0.26% | 4.67% | (7.49%) | (30.31%) | |
Return on Tangible Assets |
0.15% | 1.13% | (6.51%) | (25.43%) | |
Average Days of Receivables |
96.21 | 105.84 | 102.03 | 76.32 | |
Free Cash Flow per Share |
0.35 | (0.13) | (1.10) | (0.81) | |
Free Cash Flow |
17.85 | (6.75) | (54.99) | (40.05) | |
Capital Expenditures |
(3.55) | (3.50) | (4.79) | (5.82) | |
| Other line items | |||||
Cash ROIC |
3.06% | (1.23%) | (10.04%) | (7.10%) | |
Accounts Receivable Turnover |
4.48 | 5.11 | 4.79 | 3.74 | |
Accounts Payable Turnover |
7.41 | 6.15 | 6.66 | 4.03 | |
Inventory Turnover |
1.77 | 1.59 | 1.37 | 1.15 | |
Average Days of Payables |
59.91 | 61.96 | 47.30 | 74.09 | |
Days of Inventory on Hand |
189.28 | 215.34 | 270.80 | 355.23 | |
Tax Rate |
(0.90) | (0.78) | 0.08 | (0.02) | |
Research and Development Expense of Revenue |
0.00% | 11.28% | 13.31% | 16.73% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 53.26% | 61.45% | 78.65% | |
Share Based Compensation of Revenue |
7.77% | 8.29% | 10.12% | 12.77% | |
Operating CF/Net income |
40.37 | (0.85) | 2.39 | 0.43 | |
Depreciation/Fixed assets |
0.00 | 0.14 | 0.12 | 0.12 | |
Capex/Depreciation |
0.00 | (0.37) | (0.58) | (0.68) | |
Revenue per Share |
6.50 | 6.75 | 5.82 | 4.83 | |
Operating CF per Share |
0.42 | (0.06) | (1.01) | (0.69) | |
Capex per Share |
(0.07) | (0.07) | (0.10) | (0.12) | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 4 Nov 2026